CME Group Inc. (NASDAQ:CME) Expected to Post Earnings of $1.60 Per Share

Brokerages predict that CME Group Inc. (NASDAQ:CME) will announce earnings per share of $1.60 for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for CME Group’s earnings, with the lowest EPS estimate coming in at $1.51 and the highest estimate coming in at $1.68. CME Group posted earnings of $1.38 per share in the same quarter last year, which indicates a positive year over year growth rate of 15.9%. The firm is expected to issue its next earnings report before the market opens on Wednesday, October 27th.

On average, analysts expect that CME Group will report full-year earnings of $6.65 per share for the current year, with EPS estimates ranging from $6.43 to $6.77. For the next year, analysts forecast that the company will post earnings of $7.19 per share, with EPS estimates ranging from $6.75 to $7.37. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow CME Group.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.59 by $0.05. CME Group had a net margin of 41.64% and a return on equity of 8.33%. The firm had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.17 billion.

Several equities research analysts recently commented on CME shares. Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price target on the stock in a research note on Tuesday. TheStreet cut shares of CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Finally, Morgan Stanley boosted their price objective on shares of CME Group from $228.00 to $229.00 and gave the company an “equal weight” rating in a research report on Thursday, July 1st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $210.83.

In other CME Group news, Director Martin J. Gepsman sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, September 13th. The stock was sold at an average price of $188.53, for a total transaction of $188,530.00. Following the completion of the transaction, the director now owns 24,468 shares in the company, valued at $4,612,952.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sean Tully sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total transaction of $1,001,000.00. Following the completion of the transaction, the insider now directly owns 23,479 shares of the company’s stock, valued at approximately $4,700,495.80. The disclosure for this sale can be found here. Insiders have sold a total of 9,000 shares of company stock worth $1,786,150 over the last three months. Insiders own 0.30% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in CME. Dimensional Fund Advisors LP boosted its holdings in shares of CME Group by 4.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 863,553 shares of the financial services provider’s stock valued at $157,190,000 after acquiring an additional 38,146 shares in the last quarter. AE Wealth Management LLC grew its holdings in CME Group by 8.8% in the first quarter. AE Wealth Management LLC now owns 2,130 shares of the financial services provider’s stock valued at $435,000 after purchasing an additional 172 shares during the period. Stratos Wealth Partners LTD. grew its stake in CME Group by 6.0% during the first quarter. Stratos Wealth Partners LTD. now owns 1,581 shares of the financial services provider’s stock worth $323,000 after buying an additional 89 shares during the period. Meeder Asset Management Inc. boosted its stake in shares of CME Group by 36.9% in the first quarter. Meeder Asset Management Inc. now owns 2,302 shares of the financial services provider’s stock valued at $470,000 after purchasing an additional 620 shares during the period. Finally, Regentatlantic Capital LLC raised its holdings in CME Group by 49.8% in the first quarter. Regentatlantic Capital LLC now owns 3,157 shares of the financial services provider’s stock valued at $645,000 after acquiring an additional 1,050 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

CME Group stock traded down $0.38 during mid-day trading on Tuesday, reaching $188.85. 1,136,072 shares of the company’s stock were exchanged, compared to its average volume of 1,443,937. CME Group has a twelve month low of $146.89 and a twelve month high of $221.82. The company has a fifty day moving average of $204.38 and a 200-day moving average of $208.14. The company has a market cap of $67.82 billion, a P/E ratio of 35.30 and a beta of 0.43. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 27th. Stockholders of record on Friday, September 10th will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 9th. CME Group’s dividend payout ratio is currently 53.57%.

About CME Group

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Featured Story: How to build a Fibonacci channel

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.